Company Overview - Intuitive Surgical, Inc. (ISRG) is a leader in modern medical technology, particularly in robotic surgery, holding approximately 70% market share and an installed base of 12,000 systems [1][3] - The company generates nearly 85% of its revenue from recurring sources, supported by its da Vinci ecosystem, which includes the newly launched da Vinci 5 system [1][2] Market Potential - The robotic surgery market is projected to grow from around $16 billion in 2026 to over $50 billion by 2035, driven by increased adoption in general surgery and international markets [3] - Significant growth opportunities exist in general surgery, where penetration remains low, despite meaningful advancements in urology and gynecology [3] Competitive Position - Intuitive Surgical's competitive edge is bolstered by high switching costs, extensive surgeon training integration, a vast patent portfolio, and a robust data moat from millions of procedures [4] - The company faces competition from Medtronic and Johnson & Johnson, but its established ecosystem, scale advantages, and proven clinical outcomes position it well for sustained leadership and market share capture [4]